ALLMedicine™ Subdural Hematoma Center

Jul 2nd, 2022 - Background: Biotin-thiamine-responsive basal ganglia disease (BTBGD) is a rare, treatable autosomal recessive neurometabolic disorder. This condition eventually leads to severe disability and death if not treated correctly. The clinical features o...

Jun 30th, 2022 - This review aimed to identify the demographic and clinical differences between those older adults admitted directly under neurosurgical care and those that were not, and whether EMS clinicians could use these differences to improve patient triage....

Jun 30th, 2022 - Middle meningeal artery embolization (MMAE) is a novel approach for treatment of chronic subdural hematoma (cSDH). Studies comparing different procedural techniques for MMAE are lacking. It is unclear whether isolated use of coils results in subop...

Jun 28th, 2022 - Background A subdural hematoma (SDH) is a common neurosurgical disorder that often requires surgical intervention. It is a type of intracranial hemorrhage that occurs beneath the dura (essentially, a collection of blood over the surface of the bra...

Jun 28th, 2022 - Background A subdural hematoma (SDH) is a common neurosurgical disorder that often requires surgical intervention. It is a type of intracranial hemorrhage that occurs beneath the dura (essentially, a collection of blood over the surface of the bra...

Jun 22nd, 2022 - Chronic subdural hematoma (CSDH) is a very common hemorrhagic disease of the nervous system, accounting for about 10% of hemorrhagic strokes. The incidence rate of elderly people over 65 years old is 58.1/100,000, and the incidence rate is increas...

Jun 14th, 2022 - The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the Onyx™ Liquid Embolic System (LES) for treatment of symptomatic subacute or chronic subdural hematoma (SDH)

Jun 8th, 2022 - The study objective is to provide an assessment of the safety and effectiveness of Middle Meningeal Artery (MMA) embolization with SQUID for the management of Chronic Subdural Hematoma (cSDH).

Jun 1st, 2022 - The purpose of our study is to conduct a prospective cohort study to assess the safety and effectiveness of MMA embolization for the treatment of CSDH. All patients with CSDH presenting to the emergency room or to neurosurgical outpatient clinic w...

May 31st, 2022 - Patients with a chronic subdural hematoma (cSDH), that is, a blood accumulation between two meninges developing over a long period of time, often have recurrent bleedings after an initial operation. The study aims to show that additional surgery r...

Jun 15th, 2022 - THE CASE Declan M*, a 42-year-old man, presents as a new patient for general medical care. One year ago, he sustained a severe frontal traumatic brain injury (TBI) when he was hit by a car while crossing a street.

Jan 31st, 2022 - Fifteen years ago, Mrs. Smith was hospitalized for a dural sinus thrombosis.

Oct 26th, 2021 - Prostate cancer is a highly hetero-geneous disease, with individual tumor cells having distinct genomic and pheno-typic characteristics, resulting in a great deal of variability in patients’ disease course. Although some pros-tate cancers are slow...

Jun 4th, 2021 - An Alabama neurosurgeon who was charged with manslaughter in the death of a third-year medical student is now facing a malpractice suit alleging he performed the wrong brain surgery. The brain surgery patient's widow, Christine Metzger, is suing J...

Jan 20th, 2021 - This transcript has been edited for clarity. Dear colleagues, I'm Christoph Diener from the University of Duisburg-Essen in Germany, here to tell you about five interesting neurology studies published in December 2020. The first study of interest ...